Traws Pharma, Inc.
TRAW
2 insider filings · Latest: Apr 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 28 9:41 PM | ORBIMED ADVISORS LLC10% Owner | Purchase | 597,729 | $1.67 | $998.2K | 1,203,250(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 28 9:41 PM | ORBIMED ADVISORS LLC10% Owner | Purchase | 2,988,645 | $1.67 | 1,793,187(I) | View → |
| Mar 8, 2026 | Apr 8 2:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 104,544 | $1.60 | 104,544(D) | View → |
| Dec 12, 2025 | Apr 8 2:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 61,571 | $2.33 | 61,571(D) | View → |
| Oct 12, 2025 | Apr 8 2:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 32,406 | $3.01 | 32,406(D) | View → |